Fundz
Real-time · AI · Cross-signal

Teijin Limited and Hilleman Laboratories just moved. Here's exactly what to do next.

Who to reach, what to say, and why now — on Teijin Limited and Hilleman Laboratories, plus every contract, funding round, and exec hire that follows. Verified, ICP-ranked contacts on demand (email + mobile).

Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.

Choose your planRequest a demo
Watch the 2-minute tour · with sound

Teijin Limited and Hilleman Laboratories Form Strategic Partnership to Expand CDMO Services in Cell and Gene Therapy

Oct 30, 2024over 1 year ago

Contract Type

partnership

SingaporeBiotechnology

Description

Teijin Limited and Hilleman Laboratories have signed a Memorandum of Understanding to establish a strategic international business partnership with the goal of promoting the expansion in contract development and manufacturing organization (CDMO) business in the field of cell and gene therapy. The partnership aims to strengthen support for Japanese customers aiming to expand into the Asia-Pacific region and attract overseas customers from Singapore and surrounding areas to the Japanese market.

Company Information

Company

Teijin Limited and Hilleman Laboratories

Location

Singapore

About

Teijin Limited is a Japanese multinational and Hilleman Laboratories is a biotechnology company based in Singapore.

Predictive Intelligence
Strategic

ML-powered predictions for Teijin Limited and Hilleman Laboratories's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months